Lisanti Capital Growth’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q2
Sell
-4,605
Closed -$292K 115
2016
Q1
$292K Buy
4,605
+220
+5% +$14K 0.35% 94
2015
Q4
$492K Buy
+4,385
New +$492K 0.52% 79
2014
Q4
Sell
-25,170
Closed -$1.43M 104
2014
Q3
$1.43M Buy
+25,170
New +$1.43M 0.72% 66
2014
Q2
Sell
-14,595
Closed -$714K 109
2014
Q1
$714K Buy
+14,595
New +$714K 0.31% 88